Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mark

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Swiss Medical Weekly|June 5, 2002
Assessment of digital clubbing in medical inpatients by digital photography and computerized analysisDaniela Husarik, Stephan R Vavricka, Michael Mark, et al.
Metabolism: Clinical and Experimental|January 17, 2016
The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptinMatthias Kern, Nora Klöting, Michael Mark, et al.
The Journal of Endocrinology|July 5, 2012
The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic miceJacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, et al.
Heliyon|May 8, 2023
Application of xanthan gum as coagulant-aid for decolorization of synthetic Congo red wastewaterMichael Mark Sudirgo, Ryan Aristo Surya, Hans Kristianto, et al.
FEBS Letters|January 4, 2012
Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporterRolf Grempler, Robert Augustin, Stefanie Froehner, et al.
Medical Molecular Morphology|September 20, 2013
Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitisThomas Klein, Masato Fujii, Jan Sandel, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 18, 2014
Tobacco education in U.S. respiratory care programsKaren Suchanek Hudmon, Michael Mark, Adam L Livin, et al.
Clinical Chemistry and Laboratory Medicine|October 8, 2008
Association between plasma thiols and immune activation marker neopterin in stable coronary heart diseaseKatharina Schroecksnadel, Roland B Walter, Guenter Weiss, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2015
Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experienceViktoria Volk, Richard Cathomas, Michael Mark, et al.
Diabetes, Obesity & Metabolism|April 21, 2021
Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetesThomas Klein, Harald Tammen, Michael Mark, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Swiss Medical Weekly|June 5, 2002
Assessment of digital clubbing in medical inpatients by digital photography and computerized analysisDaniela Husarik, Stephan R Vavricka, Michael Mark, et al.
Metabolism: Clinical and Experimental|January 17, 2016
The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptinMatthias Kern, Nora Klöting, Michael Mark, et al.
The Journal of Endocrinology|July 5, 2012
The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic miceJacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, et al.
Heliyon|May 8, 2023
Application of xanthan gum as coagulant-aid for decolorization of synthetic Congo red wastewaterMichael Mark Sudirgo, Ryan Aristo Surya, Hans Kristianto, et al.
FEBS Letters|January 4, 2012
Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporterRolf Grempler, Robert Augustin, Stefanie Froehner, et al.
Medical Molecular Morphology|September 20, 2013
Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitisThomas Klein, Masato Fujii, Jan Sandel, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 18, 2014
Tobacco education in U.S. respiratory care programsKaren Suchanek Hudmon, Michael Mark, Adam L Livin, et al.
Clinical Chemistry and Laboratory Medicine|October 8, 2008
Association between plasma thiols and immune activation marker neopterin in stable coronary heart diseaseKatharina Schroecksnadel, Roland B Walter, Guenter Weiss, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2015
Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experienceViktoria Volk, Richard Cathomas, Michael Mark, et al.
Diabetes, Obesity & Metabolism|April 21, 2021
Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetesThomas Klein, Harald Tammen, Michael Mark, et al.
Pageof 9